Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Eduardo Vilar"'
Autor:
V V Pavan Kedar Mukthinuthalapati, Samuel Akinyeye, Zachary P Fricker, Moinuddin Syed, Eric S Orman, Lauren Nephew, Eduardo Vilar-Gomez, James Slaven, Naga Chalasani, Maya Balakrishnan, Michelle T Long, Bashar M Attar, Marwan Ghabril
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0211811 (2019)
BackgroundSafety-net hospitals provide care for racially/ethnically diverse and disadvantaged urban populations. Their hospitalized patients with cirrhosis are relatively understudied and may be vulnerable to poor outcomes and racial/ethnic dispariti
Externí odkaz:
https://doaj.org/article/842206048a4d44098365fd6791e0e864
Autor:
Amir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, Ganiraju Manyam, Bryan K Kee, David R Fogelman, Arvind Dasari, Kanwal Raghav, Eduardo Vilar, Shanequa Manuel, Imad Shureiqi, Robert A Wolff, Keyur P Patel, Raja Luthra, Kenna Shaw, Cathy Eng, Dipen M Maru, Mark J Routbort, Funda Meric-Bernstam, Scott Kopetz
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0173345 (2017)
SMAD4 is an essential mediator in the transforming growth factor-β pathway. Sporadic mutations of SMAD4 are present in 2.1-20.0% of colorectal cancers (CRCs) but data are limited. In this study, we aimed to evaluate clinicopathologic characteristics
Externí odkaz:
https://doaj.org/article/bfd5486e32c44fa5ab5f0b9a3eb57fca
Autor:
Allan A Lima Pereira, Maria Pia Morelli, Michael Overman, Bryan Kee, David Fogelman, Eduardo Vilar, Imad Shureiqi, Kanwal Raghav, Cathy Eng, Shanequa Manuel, Shadarra Crosby, Robert A Wolff, Kimberly Banks, Richard Lanman, AmirAli Talasaz, Scott Kopetz, Van Morris
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183949 (2017)
Circulating cell-free DNA (cfDNA) isolated from the plasma of cancer patients (pts) has been shown to reflect the genomic mutation profile of the tumor. However, physician and patient assessment of clinical utility of these assays in patients with me
Externí odkaz:
https://doaj.org/article/01cf886af3f24f81a41645e8f9fd15e1
Autor:
Eduardo Vilar Gomez, Ana Torres Gonzalez, Luis Calzadilla Bertot, Ali Yasells Garcia, Yoan Sanchez Rodriguez, Yadina Martinez Perez
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e95736 (2014)
BACKGROUND: Arterial blood pressure (BP) is a reliable marker of circulatory dysfunction in cirrhotic patients. There are no prospective studies evaluating the association between different levels of arterial BP and ascites development in compensated
Externí odkaz:
https://doaj.org/article/7670b0ede7b342b688f97177eeeff0e7
Autor:
Bashar M. Attar, Moinuddin Syed, Samuel Akinyeye, Maya Balakrishnan, James E. Slaven, Lauren Nephew, Zachary P. Fricker, Eduardo Vilar-Gomez, Naga Chalasani, V.V. Pavan Kedar Mukthinuthalapati, Michelle T. Long, Eric S. Orman, Marwan Ghabril
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 3, p e0211811 (2019)
PLoS ONE, Vol 14, Iss 3, p e0211811 (2019)
BackgroundSafety-net hospitals provide care for racially/ethnically diverse and disadvantaged urban populations. Their hospitalized patients with cirrhosis are relatively understudied and may be vulnerable to poor outcomes and racial/ethnic dispariti
Autor:
Amir Ali Talasaz, Shanequa Manuel, Scott Kopetz, David R. Fogelman, Richard B. Lanman, Allan Andresson Lima Pereira, Maria Pia Morelli, Michael J. Overman, Bryan K. Kee, Van K. Morris, Shadarra Crosby, Imad Shureiqi, Kanwal Pratap Singh Raghav, Kimberly C. Banks, Robert A. Wolff, Eduardo Vilar, Cathy Eng
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183949 (2017)
PLoS ONE
PLoS ONE
Background Circulating cell-free DNA (cfDNA) isolated from the plasma of cancer patients (pts) has been shown to reflect the genomic mutation profile of the tumor. However, physician and patient assessment of clinical utility of these assays in patie
Autor:
Mark J. Routbort, Cathy Eng, Bryan K. Kee, Eduardo Vilar, David R. Fogelman, Robert A. Wolff, Amir Mehrvarz Sarshekeh, Keyur P. Patel, Michael J. Overman, Dipen M. Maru, Arvind Dasari, Ganiraju C. Manyam, Shailesh Advani, Imad Shureiqi, Scott Kopetz, Raja Luthra, Kanwal Pratap Singh Raghav, Shanequa Manuel, Kenna R. Mills Shaw, Funda Meric-Bernstam
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0173345 (2017)
SMAD4 is an essential mediator in the transforming growth factor-β pathway. Sporadic mutations of SMAD4 are present in 2.1-20.0% of colorectal cancers (CRCs) but data are limited. In this study, we aimed to evaluate clinicopathologic characteristics
Autor:
Luis Calzadilla Bertot, Eduardo Vilar Gomez, Ali Yasells Garcia, Ana González, Yoan Antonio Sánchez Rodríguez, Yadina Martinez Perez
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e95736 (2014)
PLoS ONE
PLoS ONE
Background Arterial blood pressure (BP) is a reliable marker of circulatory dysfunction in cirrhotic patients. There are no prospective studies evaluating the association between different levels of arterial BP and ascites development in compensated
Autor:
Gomez EV; Department of Research and Clinical Experimentation, National Institute of Gastroenterology, Havana, Cuba., Gonzalez AT; Department of Hepatology, National Institute of Gastroenterology, Havana, Cuba., Bertot LC; Department of Hepatology, National Institute of Gastroenterology, Havana, Cuba., Yasells Garcia A; Department of Hepatology, National Institute of Gastroenterology, Havana, Cuba., Rodriguez YS; Department of Hepatology, National Institute of Gastroenterology, Havana, Cuba., Perez YM; Department of Hepatology, National Institute of Gastroenterology, Havana, Cuba.
Publikováno v:
PloS one [PLoS One] 2014 Apr 22; Vol. 9 (4), pp. e95736. Date of Electronic Publication: 2014 Apr 22 (Print Publication: 2014).